Wellgistics Health, Inc. (NASDAQ:WGRX – Get Free Report) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totaling 695,222 shares, a decrease of 19.7% from the December 15th total of 865,399 shares. Currently, 1.4% of the shares of the company are sold short. Based on an average trading volume of 442,337 shares, the short-interest ratio is currently 1.6 days. Based on an average trading volume of 442,337 shares, the short-interest ratio is currently 1.6 days. Currently, 1.4% of the shares of the company are sold short.
Hedge Funds Weigh In On Wellgistics Health
Institutional investors have recently bought and sold shares of the company. ORG Wealth Partners LLC acquired a new stake in shares of Wellgistics Health in the third quarter valued at $89,000. Raymond James Financial Inc. lifted its stake in Wellgistics Health by 593.8% during the third quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after purchasing an additional 50,000 shares during the last quarter. Finally, Heights Capital Management Inc. acquired a new position in Wellgistics Health in the third quarter valued at approximately $2,588,000.
Wellgistics Health Price Performance
Wellgistics Health stock opened at $0.41 on Tuesday. Wellgistics Health has a 12-month low of $0.34 and a 12-month high of $7.04. The stock has a market cap of $36.40 million and a P/E ratio of -0.35. The company has a 50-day moving average price of $0.50 and a 200 day moving average price of $0.78. The company has a current ratio of 0.39, a quick ratio of 0.16 and a debt-to-equity ratio of 1.86.
Analysts Set New Price Targets
View Our Latest Research Report on Wellgistics Health
About Wellgistics Health
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Recommended Stories
- Five stocks we like better than Wellgistics Health
- Wall Street Stockpicker Names #1 Stock of 2026
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
